SCM
SLDB icon

Sterling Capital Management’s Solid Biosciences SLDB Stock Holding History

Sterling Capital Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.48K Sell
949
-1,004
-51% -$7.61K ﹤0.01% 2250
2026
Q1 		$14.1K Sell
1,953
-1,445
-43% -$9.29K ﹤0.01% 2191
2025
Q4 		$19.2K Sell
3,398
-670
-16% -$3.63K ﹤0.01% 2250
2025
Q3 		$25.1K Buy
4,068
+2,286
+128% +$13.4K ﹤0.01% 2031
2025
Q2 		$8.68K Buy
1,782
+1,409
+378% +$4.98K ﹤0.01% 2225
2025
Q1 		$1.38K Sell
373
-331
-47% -$1.42K ﹤0.01% 2710
2024
Q4 		$2.82K Buy
704
+637
+951% +$3.5K ﹤0.01% 2668
2024
Q3 		$467 Buy
+67
New +$543 ﹤0.01% 2906

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sterling Capital Management's SLDB Position: Q2 2026 in Review

Sterling Capital Management reduced its Solid Biosciences (SLDB) stake by 51% in Q2 2026, selling an estimated $7.61K and leaving 949 shares worth $9.48K. The position accounts for ﹤0.01% of the portfolio, ranked #2250.

Sterling Capital Management first reported a position in SLDB in Q3 2024 and has held it in 8 quarters since. The position peaked at $25.1K in Q3 2025. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Sterling Capital Management held 949 shares of Solid Biosciences worth $9.48K as of Q2 2026.
  • Sterling Capital Management sold 1,004 Solid Biosciences shares in Q2 2026, an estimated $7.61K.
  • Solid Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2250 holding.
  • Sterling Capital Management first reported a position in Solid Biosciences in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Solid Biosciences position peaked at $25.1K in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.